av/takeda--big.svg

COM:TAKEDA

Takeda Pharmaceutical Company Limited

  • Stock

Last Close

4,182.00

21/11 06:45

Market Cap

6.77T

Beta: -

Volume Today

3.98M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
net income
109.56B
-
-143.03B
230.56%
83.48B
158.36%
115.51B
38.37%
186.71B
61.63%
109.01B
41.61%
44.29B
59.37%
376.17B
749.34%
230.17B
38.81%
317.04B
37.74%
144.07B
54.56%
depreciation and amortization
215.74B
-
260.95B
20.95%
197.38B
24.36%
222.79B
12.87%
182.13B
18.25%
272.45B
49.59%
583.65B
114.23%
559.67B
4.11%
583.15B
4.20%
664.40B
13.93%
728.00B
9.57%
deferred income tax
49.29B
-
-2.40B
104.88%
37.06B
1,642.20%
27.83B
24.90%
30.50B
9.57%
-14.12B
146.29%
-105.04B
644.04%
-9.94B
90.54%
72.41B
828.71%
58.05B
19.82%
stock based compensation
-213.78B
-
-115.30B
46.06%
-47.31B
58.97%
-159.93B
238.04%
18.61B
111.64%
20.08B
7.92%
29.12B
45.00%
37.66B
29.33%
43.37B
15.16%
60.67B
39.88%
70.87B
16.81%
change in working capital
-57.12B
-
262.33B
559.28%
-267.21B
201.86%
29.68B
111.11%
13.40B
54.83%
75.95B
466.59%
94.67B
24.66%
275.78B
191.30%
98.61B
64.25%
-25.26B
125.62%
-263.56B
943.22%
accounts receivables
-42.50B
-
-32.52B
23.50%
12.37B
138.05%
-37.31B
401.61%
-647M
98.27%
-13.38B
1,968.32%
-34.83B
160.25%
-9.32B
73.25%
127.29B
1,466.40%
75.13B
40.98%
15.10B
79.90%
inventory
-16.92B
-
-14.55B
14.01%
-6.84B
52.95%
3.89B
156.77%
13.72B
253.04%
58.68B
327.71%
137.49B
134.32%
25.98B
81.11%
-46.15B
277.64%
-79.16B
71.52%
-115.74B
46.22%
accounts payables
-42.33B
-
-7.08B
83.27%
17.91B
352.89%
42.56B
137.62%
6.86B
83.88%
-16.41B
339.19%
-29.93B
82.37%
210.02B
801.66%
75.55B
64.03%
-53.13B
170.33%
-9.89B
81.38%
other working capital
44.63B
-
316.47B
609.02%
-290.65B
191.84%
20.55B
107.07%
-6.53B
131.78%
47.06B
820.72%
21.94B
53.39%
49.10B
123.81%
-58.09B
218.31%
31.90B
154.91%
-153.03B
579.72%
other non cash items
44.64B
-
-80.02B
279.27%
22.10B
127.61%
25.49B
15.35%
-53.49B
309.87%
-134.89B
152.17%
23.06B
117.10%
-228.42B
1,090.41%
95.40B
141.77%
-97.74B
202.45%
1.60T
1,735.27%
net cash provided by operating activities
148.34B
-
182.52B
23.04%
25.49B
86.03%
261.36B
925.31%
377.85B
44.57%
328.48B
13.07%
669.75B
103.89%
1.01T
50.94%
1.12T
11.10%
977.16B
13.00%
640.32B
34.47%
investments in property plant and equipment
-78.52B
-
-108.72B
38.46%
-84.86B
21.95%
-112.03B
32.02%
-128.26B
14.49%
-134.11B
4.56%
-217.71B
62.33%
-236.47B
8.62%
-186.04B
21.33%
-633.69B
240.63%
-480.73B
24.14%
acquisitions net
-3.34B
-
-20.43B
511.31%
-7.05B
65.48%
-524.74B
7,341.00%
56.75B
110.82%
-2.87T
5,163.35%
456.66B
115.89%
530.39B
16.15%
-21.48B
104.05%
7.96B
137.06%
-4.74B
159.50%
purchases of investments
-141.69B
-
-3.57B
97.48%
-40.02B
1,020.61%
-82.11B
105.18%
-88.66B
7.98%
-17.10B
80.71%
-7.55B
55.84%
-12.60B
66.81%
-8.34B
33.78%
-10.15B
21.70%
-6.77B
33.35%
sales maturities of investments
52.27B
-
165.36B
216.36%
56.45B
65.86%
75.27B
33.33%
40.74B
45.87%
65.03B
59.62%
49.40B
24.04%
74.60B
51.01%
16.92B
77.32%
22.25B
31.52%
8.02B
63.96%
other investing activites
12.67B
-
58.71B
363.48%
4.26B
92.74%
-12.09B
383.47%
26.08B
315.79%
124.03B
375.56%
11.32B
90.87%
37.60B
232.11%
808M
97.85%
6.53B
707.67%
-4.00B
161.34%
net cash used for investing activites
-158.61B
-
91.35B
157.59%
-71.21B
177.95%
-655.69B
820.81%
-93.34B
85.76%
-2.84T
2,937.97%
292.12B
110.30%
393.53B
34.72%
-198.13B
150.35%
-607.10B
206.42%
-488.21B
19.58%
debt repayment
-167M
-
-119.49B
71,452.69%
-100.01B
16.30%
-191.76B
91.74%
-142.66B
25.61%
-1.74B
98.78%
-731.06B
41,890.64%
-1.84T
151.69%
-849.81B
53.82%
-400.07B
52.92%
-116.16B
70.96%
common stock issued
-5.24B
-
145.11B
2,870.78%
660.23B
355.00%
-18.84B
102.85%
3.13T
16,702.09%
17.76B
99.43%
1.07T
5,938.33%
141.13B
86.84%
6.45B
95.43%
common stock repurchased
-17.59B
-
-22.35B
27.06%
-23.12B
3.45%
-18.76B
18.86%
-1.17B
93.75%
-3.74B
218.86%
-2.14B
42.71%
-77.53B
3,521.25%
-26.93B
65.27%
-2.33B
91.36%
dividends paid
-142.13B
-
-141.64B
0.35%
-141.54B
0.07%
-141.69B
0.11%
-141.89B
0.14%
-142.95B
0.75%
-282.58B
97.68%
-283.36B
0.27%
-283.67B
0.11%
-279.42B
1.50%
-287.19B
2.78%
other financing activites
243.74B
-
-17.04B
106.99%
-6.05B
64.51%
-13.76B
127.51%
-4.08B
70.38%
-36.23B
788.84%
-5.59B
84.56%
-35.00B
525.82%
-385M
98.90%
-9.18B
2,283.64%
-26.10B
184.43%
net cash used provided by financing activities
101.44B
-
-301.00B
396.72%
-124.84B
58.52%
289.90B
332.22%
-326.23B
212.53%
2.95T
1,003.13%
-1.01T
134.12%
-1.09T
8.27%
-1.07T
1.66%
-709.15B
33.74%
-254.04B
64.18%
effect of forex changes on cash
29.30B
-
16.33B
44.28%
-33.26B
303.69%
-5.74B
82.73%
-4.57B
20.51%
-31.27B
584.97%
-21.77B
30.39%
12.50B
157.43%
28.76B
130.05%
22.93B
20.27%
26.20B
14.28%
net change in cash
120.47B
-
-10.80B
108.97%
-203.82B
1,786.32%
-131.97B
35.25%
-46.73B
64.59%
407.12B
971.22%
-65.11B
115.99%
328.61B
604.71%
-116.53B
135.46%
-316.17B
171.32%
228.24B
172.19%
cash at beginning of period
545.58B
-
666.05B
22.08%
655.24B
1.62%
451.43B
31.11%
341.25B
24.41%
294.97B
13.56%
702.72B
138.23%
637.61B
9.27%
966.22B
51.54%
849.70B
12.06%
229.56B
72.98%
cash at end of period
666.05B
-
655.24B
1.62%
451.43B
31.11%
319.45B
29.23%
294.52B
7.80%
702.09B
138.38%
637.61B
9.18%
966.22B
51.54%
849.70B
12.06%
533.53B
37.21%
457.80B
14.19%
operating cash flow
148.34B
-
182.52B
23.04%
25.49B
86.03%
261.36B
925.31%
377.85B
44.57%
328.48B
13.07%
669.75B
103.89%
1.01T
50.94%
1.12T
11.10%
977.16B
13.00%
640.32B
34.47%
capital expenditure
-78.52B
-
-108.72B
38.46%
-84.86B
21.95%
-112.03B
32.02%
-128.26B
14.49%
-134.11B
4.56%
-217.71B
62.33%
-236.47B
8.62%
-186.04B
21.33%
-633.69B
240.63%
-480.73B
24.14%
free cash flow
69.82B
-
73.80B
5.70%
-59.37B
180.44%
149.34B
351.55%
249.59B
67.13%
194.37B
22.13%
452.04B
132.57%
774.46B
71.33%
937.07B
21.00%
343.47B
63.35%
159.59B
53.54%

All numbers in (except ratios and percentages)